Back to search

University of Leeds

Genetic and Molecular Investigation of the Schnitzler Syndrome

Abstract

dc:description.abstract

The Schnitzler Syndrome (SchS) is a rare, autoinflammatory condition with an unknown pathological mechanism, but treatment with IL-1 inhibition provides remarkable efficacy. Exhibiting two main defining features: (1) an urticarial rash and (2) an IgM gammopathy, this IL-1 mediated disease phenotypically bears stark resemblance to NLRP3-associated inflammatory disease. The latter monogenic entity is known to show gain-of-function and pathological mutations in the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome. Furthermore, 20% of SchS patients go on to develop overt lymphoproliferative diseases, namely Waldenström's Macroglobulinaemia (WM). This condition presents with a specific mutation in the Myeloid Differentiation Primary Response (MYD88) gene in over 90% of patients. Against the backdrop of these imperative findings, the work presented in this thesis therefore examines the role of these immunological constituents in SchS, via the assessment of mutations in NLRP3 and MYD88 alongside a panel of genes frequently mutated in haematological malignancies. Identification of a causative gene would not only improve molecular diagnosis, but allows for potential unearthing of genotype-phenotype correlations. Since the identification of this condition in 1972, the features and consequences of the IgM gammopathy has remained elusive. In a bid to delineate the latter, examination of the heavy chain of the immunoglobulin repertoire would therefore indicate aspects of the adaptive immune response integral to formation of the monoclonal component. A biased repertoire would therefore indicate the existence of a clonal B-cell population. Additionally, isolation of SchS-IgM and interrogation of a protein array comprising of over 15,700 human proteins further indicates whether this element causes pathological effects. Exploration of the genetic and molecular components did not expose a common mechanism through which SchS manifests, ruling out the notion that NLRP3, MYD88 and other associated genes are universally causative of this enigmatic disease. Assessment of the IgH repertoire indicated that SchS patients show evidence of expanded B-cell populations, and together with protein array analysis demonstrating the preference of IgM binding to nuclear antigens, this study supports the theory that SchS is a clonal disorder. The breadth and depth of these findings broadens the currently limited scientific knowledge pertaining to SchS, forming the basis upon which further investigations can commence.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pathak, Punam Shelly
Advisors dc:contributor.advisor
  • Savic, Sinisa
  • Newton, Darren
  • Doody, Gina

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.806839

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Pathak, Punam Shelly. Genetic and Molecular Investigation of the Schnitzler Syndrome. doctoral thesis, University of Leeds, 2019.